Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Catalent Restructures Organization To Support Biologics Development

By Catalent Pharma Solutions | April 27, 2018

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, announced key organizational changes within its biologics business to further align its organization with customer demand for integrated and comprehensive, end-to-end biologics solutions.

The reorganization follows the company’s 2017 acquisition of Cook Pharmica LLC, and with it the addition of its 875,000-square-foot facility in Bloomington, IN to provide comprehensive biologics development, analytical services, and drug substance and drug product manufacturing.

Tedd Green named senior vice president of Catalent Biologics.

Tedd Green, former President of Cook Pharmica, becomes senior vice president of Catalent Biologics, and will have responsibility for the entire biologics business. He will continue to report to Barry Littlejohns, president, Catalent Biologics and Specialty Drug Delivery, and will also act as a member of Catalent’s executive leadership team. Green will be based at the Bloomington facility.

Mike Riley becomes vice president and general Mmnager of Drug Substance and Bioanalytical services for Catalent Biologics. He will lead the company’s biologics manufacturing business, including its mammalian cell-line engineering and biomanufacturing capabilities, and its broad bioanalytical capabilities based at several sites across Catalent’s global network.

Cory Lewis will take on the new role of vice president and general manager of the Catalent Biologics Drug Product business, with a focus on successfully growing the Catalent Biologics drug product offerings both in the U.S. and in Europe.

In a further move, Ryan Hawkins has been appointed as general manager of the Bloomington site, having been instrumental to its success through his contributions and leadership over the last 10 years.

With the $950 million acquisition of Cook Pharmica, in October 2017, Catalent further strengthened its position in integrated biologics development, clinical and commercial-scale manufacturing, and finished product supply.

The additions also boost the company’s involvement in liquid and lyophilized sterile formulation and fill-finish across vials, prefilled syringes, auto-injectors, cartridges, and safety devices, and 2,500-liter biomanufacturing capacity to augment Catalent’s existing biologics infrastructure.

(Source: Catalent Pharma Solutions)

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE